Agronomic portal Agronom.info
Categories
Language
Currency
My account
Rapeseed

Codimark

Diseases
Sclerotinia, Phomosis, Cylindrosporiosis
Country
France
Registration Year
2016
Manufacturer
Caussade Semences S.A.
Offers: 1
Where to buy
Price range
2 900 - 2 900 UAH
Views
3
Reviews
0
Producer
Caussade Semences S.A.
Description Codimark
Codimark is a mid-early winter rape hybrid characterized by high productivity and adaptability to various soil-climate conditions. It features rapid development onset, good winter hardiness, and high spring regenerative capacity, ensuring stable yields even with late sowing. The recommended planting density is 30-35 plants per square meter, promoting optimal pod formation and good branching.

The Codimark hybrid exhibits high resistance to major rape diseases such as phomopsis, cylindrical spore disease, sclerotinia, and stem base dryness. Additionally, it demonstrates excellent resistance to lodging, shattering, and drought, as well as good tolerance to temperature fluctuations and frost. These qualities make it a reliable choice for cultivation in diverse regions, with potential yields up to 55 centners per hectare.

Codimark seeds are coated with imidacloprid, thiamethoxam, and contain a polymer dye, enhancing their protection and sowing quality. The package is designed for 3 hectares and contains 1.5 million seeds. The hybrid has high oil content (about 49.4%) and low levels of glucosinolates and erucic acid, making its product valuable for processing and use in the food industry.
Specifications Codimark
Diseases
Sclerotinia
Sclerotiniosis
Phomosis
Phomosis
Cylindrosporiosis
Cylindrosporiosis
Type of Rape
Winter rape
Hybrid Type
Simple Linear
Yield Potential
50-60 cu/ha
Number of plants per hectare
500 thousand pcs/ha
Oil Content
45-50%
Glucosinolate Content, mmol
9-10
Erucic Acid Content
Low
Plant: Branching
Average
Country
France
Registration Year
2016
Catalog
Varieties
Technical Crops
Manufacturer
Caussade Semences S.A.
Where to buy Codimark
Loading...
Reviews Codimark
0comments
Sort by:Popular first
No comments yet.